Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical trials in noninfectious uveitis.

Literature DB >> 26035763

Clinical trials in noninfectious uveitis.

Jane S Kim, Jared E Knickelbein, Robert B Nussenblatt, H Nida Sen.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2015 PMID： 26035763 PMCID： PMC4455042 DOI： 10.1097/IIO.0000000000000070

Source DB: PubMed Journal: Int Ophthalmol Clin ISSN： 0020-8167

× No keyword cloud information.

88 in total

Review 1. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Authors: D A Jabs; J T Rosenbaum; C S Foster; G N Holland; G J Jaffe; J S Louie; R B Nussenblatt; E R Stiehm; H Tessler; R N Van Gelder; S M Whitcup; D Yocum
Journal: Am J Ophthalmol Date: 2000-10 Impact factor: 5.258

2. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.

Authors: K Masuda; A Nakajima; A Urayama; K Nakae; M Kogure; G Inaba
Journal: Lancet Date: 1989-05-20 Impact factor: 79.321

3. Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.

Authors: Andrew D Dick; Ilknur Tugal-Tutkun; Stephen Foster; Manfred Zierhut; S H Melissa Liew; Vladimir Bezlyak; Sofia Androudi
Journal: Ophthalmology Date: 2013-01-03 Impact factor: 12.079

4. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.

Authors: Grace Levy-Clarke; Douglas A Jabs; Russell W Read; James T Rosenbaum; Albert Vitale; Russell N Van Gelder
Journal: Ophthalmology Date: 2013-12-17 Impact factor: 12.079

5. Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis.

Authors: Amy E Cohen; Carol Assang; Michael A Patane; Stephen From; Michael Korenfeld
Journal: Ophthalmology Date: 2011-11-23 Impact factor: 12.079

6. Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases.

Authors: Joshua D Udoetuk; Yang Dai; Gui-Shuang Ying; Ebenezer Daniel; Sapna Gangaputra; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; John H Kempen
Journal: Ophthalmology Date: 2012-04-06 Impact factor: 12.079

7. One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs.

Authors: Annarita Giardina; Angelo Ferrante; Francesco Ciccia; Maria Vadalà; Ennio Giardina; Giovanni Triolo
Journal: Rheumatol Int Date: 2009-10-27 Impact factor: 2.631

8. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study.

Authors: John H Kempen; Ebenezer Daniel; Sapna Gangaputra; Kurt Dreger; Douglas A Jabs; R Oktay Kaçmaz; Siddharth S Pujari; Fahd Anzaar; C Stephen Foster; Kathy J Helzlsouer; Grace A Levy-Clarke; Robert B Nussenblatt; Teresa Liesegang; James T Rosenbaum; Eric B Suhler
Journal: Ophthalmic Epidemiol Date: 2008 Jan-Feb Impact factor: 1.648

Clinical trials in noninfectious uveitis.

Review 1. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

2. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.

3. Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.

4. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.

5. Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis.

6. Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases.

7. One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs.

8. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study.

9. Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific Northwest.

10. Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis.

Review 1. Ocular sarcoidosis: new diagnostic modalities and treatment.

Review 2. Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.

3. Choroidal thickening with serous retinal detachment in BRAF/MEK inhibitor-induced uveitis: A case report.

4. Comparative efficacy of steroid-sparing therapies for non-infectious uveitis.

Review 5. A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis.

Review 6. Neutrophil Extracellular Traps: Current Perspectives in the Eye.

Review 7. Molecular Surgery: Proteomics of a Rare Genetic Disease Gives Insight into Common Causes of Blindness.